Morbidity and mortality in the Swedish Trial in Old Patients with Management of Comorbidities in Chronic Heart Failure CLINICAL STATEMENTS AND GUIDELINES Hypertension (STOP-Hypertension). Lancet. 1991;338:1281 1285. 25. Moser M, Hebert PR. Prevention of disease progression, left ven- tricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol. 1996;27:1214 1218. doi: 10.1016/0735-1097(95)00606-0. 26. Baker DW. Prevention of heart failure. J Card Fail. 2002;8:333 346. 27. Turnbull F; Blood Pressure Lowering Treatment Trialists Collabo- ration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003;362:1527 1535. 28. Tight blood pressure control and risk of macrovascular and mi- crovascular complications in type 2 diabetes: UKPDS 38.: UK Prospective Diabetes Study Group [published correction appears in BMJ. 1999;318:29]. BMJ. 1998;317:703 713. 29. Heart Failure Society of America, Lindenfeld J, Albert NM, Boehm- er JP, Collins SP, Ezekowitz JA, Givertz MM, Katz SD, Klapholz M, Moser DK, Rogers JG, Starling RC, Stevenson WG, Tang WH, Teerlink JR, Walsh MN. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1 e194. 30. Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S; ONTARGET/TRANSCEND Investigators. Effects of telmisartan, ramipril, and their combina- tion on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascu- lar Disease. Circulation. 2009;120:1380 1389. doi: 10.1161/ CIRCULATIONAHA.109.865774. 31. Sciarretta S, Palano F, Tocci G, Baldini R, Volpe M. Antihyper- tensive treatment and development of heart failure in hyperten- sion: a bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. 